Ignite Creation Date:
2024-05-06 @ 12:33 AM
Last Modification Date:
2024-10-26 @ 10:51 AM
Study NCT ID:
NCT01608360
Status:
UNKNOWN
Last Update Posted:
2014-03-19
First Post:
2012-05-26
Brief Title:
The Effect of Intravenous Lidocaine on Pain After Thyroidectomy
Sponsor:
Chung-Ang University Hosptial Chung-Ang University College of Medicine
Organization:
Chung-Ang University Hosptial Chung-Ang University College of Medicine
Study Overview
Official Title:
Intravenous Lidocaine for Effective Pain Relief After Thyroidectomy a Prospective Randomized Double-blind Placebo-controlled Study
Status:
UNKNOWN
Status Verified Date:
2014-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This prospective randomized study aims to evaluate the effectiveness of intravenous lidocaine injection on the relief of pain in patients undergoing thyroidectomy
A total 56 patients will be randomized into one of two groupsgroup C or group I based on Excel number generation
Patients in group C will receive normal saline intravenous injection and patients in group I will receive an intravenous bolus injection of 15mgkg lidocaine followed by a continuous lidocaine infusion of 2mgkghr
Visual analogue scale pain scores fentanyl consumption the frequency at which patients pushed the buttonFPB of a patient-controlled analgesia system and presence or absence of nausea and vomiting will be recorded at 248122448 hours postoperatively
A total 56 patients will be randomized into one of two groupsgroup C or group I based on Excel number generation
Patients in group C will receive normal saline intravenous injection and patients in group I will receive an intravenous bolus injection of 15mgkg lidocaine followed by a continuous lidocaine infusion of 2mgkghr
Visual analogue scale pain scores fentanyl consumption the frequency at which patients pushed the buttonFPB of a patient-controlled analgesia system and presence or absence of nausea and vomiting will be recorded at 248122448 hours postoperatively
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None